Startup profile for Beckley Psytech: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Beckley Psytech funding, valuation and investors

Mental-health therapeutics company acquired by Atai in 2025.

Verified company research · funding, investors and latest developments

Keep track of Beckley Psytech

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Not publicly disclosed

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

acquired

acquired

Source links not recorded Last verified: 2026-11-15

Overview

Beckley Psytech developed clinical-stage mental-health therapeutics and is named in Ayuh Ventures' selected portfolio. On November 5, 2025, Atai completed the acquisition of Beckley Psytech shares it did not already own. The transaction was documented in a public filing, and the listed company changed its name to Atai Beckley.

Beckley is therefore presented here as a historical portfolio company and acquired business, rather than an independent startup currently raising a first institutional round.

Why Beckley Psytech is interesting

Beckley's history connects specialist healthcare venture investing with clinical development and a later corporate combination. The acquisition establishes a change in corporate ownership, but does not disclose Ayuh's realized investment return.

Product & use cases

The company's work focused on investigational treatments for mental-health conditions. Current pipeline, clinical-trial and corporate information should be assessed through the combined business rather than assuming the pre-acquisition structure remains unchanged.

  • Clinical development of investigational mental-health therapies.
  • Research into novel neuropsychiatric treatments.

Key facts

  • Named on Ayuh Ventures' official website.
  • Atai acquired the remaining Beckley Psytech shares on November 5, 2025.
  • The public acquisition filing records the Atai Beckley name change.

Investors in our directory

Funds linked from Beckley Psytech's profile — open a fund page for stage focus and related deal articles.

Industries

Market / IPO context

Editorial / static context — not a live quote.

FAQs about Beckley Psytech

Practical answers founders, operators, and investors typically search for.

Atai's November 5, 2025 filing states it completed the acquisition of the Beckley shares it did not already own. The listed parent became Atai Beckley.
Ayuh names Beckley Psytech in its selected portfolio. This is a historical investment relationship, not proof of current direct ownership.
The completion is documented in Atai's Form 8-K: https://ir.atai.com/static-files/284c58df-b2ca-4bb6-a582-34239a9a82e1.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.